touchPODCAST

By touchpodcast

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.

Educating physicians on a fully global... more

· Science

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about touchPODCAST:

How many episodes does touchPODCAST have?

The podcast currently has 542 episodes available.

touchPODCAST episodes:

January 21, 2025Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchHAEMATOLOGY
touchSYMPOSIUM for touchHAEMATOLOGY
Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA.
Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia (ITP) on patients and review current and emerging treatment strategies.
Session 1: Prof. Cindy Neunert considers how ITP affects patients' lives, including the impact on health-related quality of life
Session 2: Dr Mingot Castellano discusses two illustrative patient cases and the application of current management strategies
Session 3: Prof. David Kuter reviews emerging targeted treatment options for ITP, with a focus on their mechanisms of action and the latest data
Session 4: A panel discussion with all three faculty on shared decision-making and collaboration in the clinic
This touchPODCAST is for HCPs in the USA.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchhaematologyime.org
...more
1h 21min
January 06, 2025Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchONCOLOGY
touchEXPERT FOCUS for touchONCOLOGY
Listen to three experts provide insights into the optimal management of neurofibromatosis
type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs).
Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered.
The experts
Dr AeRang Kim, Children's National Hospital, Washington, DC, USA
Dr Rebecca Brown, University of Alabama School of Medicine, Birmingham, AL, USA
Dr Kaleb Yohay, NYU Langone Health, New York, NY, USA
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Springworks
Therapeutics, Inc.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/expert-focus-management-of-nf1/
...more
38min
January 06, 2025Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchNEUROLOGY
touchEXPERT FOCUS for touchNEUROLOGY
Listen to three experts provide insights into the optimal management of neurofibromatosis
type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs).
Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered.
The experts
Dr AeRang Kim, Children's National Hospital, Washington, DC, USA
Dr Rebecca Brown, University of Alabama School of Medicine, Birmingham, AL, USA
Dr Kaleb Yohay, NYU Langone Health, New York, NY, USA
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Springworks
Therapeutics, Inc.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchneurologyime.org/expert-focus-management-of-nf1/
...more
38min
December 19, 2024Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting
touchEXPERT OPINIONS for touchONCOLOGY

Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role of the multidisciplinary team in implementing this treatment modality.

The experts
Dr Laura Mertens, Netherlands Cancer Institute, Amsterdam, The Netherlands
Prof. Thomas Powles, Barts Cancer Centre, London, UK
Ms Lindsay Diamond, Icahn School of Medicine at Mount Sinai, New York, NY, USA
This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website:
www.touchONCOLOGY.com
...more
39min
December 17, 2024Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY
touchEXPERT OPINIONS for touchDERMATOLOGY
Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.
The experts
Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Dr Teresa Amaral, Tübingen University, Tübingen, Germany
This touchPODCAST is for healthcare professionals outside of the UK only
This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchdermaime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma
...more
35min
December 17, 2024Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.
The experts
Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Dr Teresa Amaral, Tübingen University, Tübingen, Germany
This touchPODCAST is for healthcare professionals outside of the UK only
This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma
...more
35min
December 04, 2024Advances in IOL technology and power calculations: Updates and innovations from 2024
touchFOCUS for touchOPHTHALMOLOGY
Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens power calculation, including how the use of artificial intelligence may help to improve accuracy, and provides an update on the latest advances in intraocular lens technology.
The expert
Dr John Ladas, Maryland Eye Consultants & Surgeons, Silver Spring, MD, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc. and Carl Zeiss Meditec, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchophthalmology.com/
...more
14min
November 27, 2024Supporting healing in epidermolysis bullosa: Innovations and new directions for care
touchFOCUS for touchDERMATOLOGY

Listen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, including its pathophysiology and clinical manifestations. In addition, she responds to questions on the role of new and emerging topical therapies for epidermolysis bullosa in patient care, with a focus on a multidisciplinary team approach.

The expert:
Prof. Amy Paller - Northwestern University Feinberg School of Medicine, Chicago, IL, USA
This touchPODCAST is for HCPs outside the UK.

This activity is funded by an independent medical education grant from Chiesi USA Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchDERMA.com
...more
19min
November 14, 2024 Primary biliary cholangitis: Appraising the changing therapeutic landscape
touchEXPERT OPINIONS for touchIMMUNOLOGY
Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis.
The expert
Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/Primary-biliary-cholangitis-therapeutic-landscape
...more
36min
November 14, 2024 Primary biliary cholangitis: Appraising the changing therapeutic landscape
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis.
The expert
Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/primary-biliary-cholangitis-therapeutic-landscape
...more
36min

FAQs about touchPODCAST:

How many episodes does touchPODCAST have?

The podcast currently has 542 episodes available.